Funding
← Back to your selection

AVP

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Jul 19, 2026
Rounds participated in
2
Confirmed lead rounds
1
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$51M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Undisclosed1

By primary sector

Biotech1
Cybersecurity1

By country

United States2

Rounds

2 in this selection
WhiteLab Genomics

WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.

$26MSeries B
Lead
Abstract

Streaming security operations that detect threats in motion and route data across an organisation’s tools.

$25MUndisclosed
Role not disclosed